BioSpace News Archive

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today the submission of an application to the Medical Devices Bureau of the Therapeutic Products Directorate in Canada that seeks to amend the Company’s existing Canadian medical device license to include distribution of the Company’s current generation ReShape Balloon™ and associated accessories.

Alan Huang, Ph.D. appointed chief scientific officer

Deltix, Inc., has released its new product suite, CryptoCortex, for institutional trading of cryptocurrencies on multiple venues. CryptoCortex is an industry first platform, designed for the specific needs of broker/dealers, exchanges, and institutional buy-side firms.

Synlogic (Nasdaq: SYBX) today announced that Aoife Brennan, M.B., B.Ch., has accepted the position of Interim President and Chief Executive Officer

Following a successful program development meeting with Food and Drug Administration’s Anti-Infective Division, Global Health Solutions shall pursue rapid development of its topical impetigo drug candidate for new drug submission.

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three and six months ended March 31, 2018.

TissueTech Inc., pioneers of the development and clinical application of amniotic tissue-based products, announced today the appointment of Dr. Frank Young as Executive Vice President of Regulatory Affairs.

Polaris Group announced that it has signed a multiyear strategic Collaboration Agreement with MD Anderson Cancer Center to utilize its Immunotherapy Platform, led by world-renowned immunotherapy pioneer Dr. James Allison, Dr. Padmanee Sharma, and Dr. Patrick Hwu, to design clinical studies and monitor biomarkers in immune functions associated with the therapies.

MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, announced today that it will participate in the Bank of America Merrill Lynch 2018 Healthcare Conference in Las Vegas, Nevada.

Engine Biosciences (“Engine”), the technology company pioneering its platform integrating big data, computation, and experimental biology to unleash faster and more effective drug discovery, today announced it has hired Stephen Harrison, Ph.D. as Chief Scientific Officer and Senior Vice President.